GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Kodu・Aktsiate loetelu・BioArctic AB

B
BioArctic AB

Suletud

290 -7.29

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

272.2

Max

312.8

Põhinäitajad
By Trading Economics
Sissetulek	-979M 97M
Müük	-897M 392M
P/E Sektori keskmine	25.665 35.733
Aktsiakasum	1.09
Kasumimarginaal	24.623
Töötajad	119
EBITDA	1.1B 1.1B

Turustatistika
By TradingEconomics
Turukapital	6.6B 27B
Eelmine avamishind	297.29
Eelmine sulgemishind	290

BioArctic AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. sept 2025, 20:46 UTC

Tulu

Costco Wholesale Posts Sales Gains in August

4. sept 2025, 20:42 UTC

Tulu

Broadcom Swings to 3Q Profit, Beats on Sales Outlook

4. sept 2025, 23:02 UTC

Market Talk

Sky Network TV's Latest Deal Looks Strategically Smart -- Market Talk

4. sept 2025, 21:46 UTC

Kuumad aktsiad

Lululemon, Broadcom, Docusign: Stocks to Watch Afterhours -- WSJ

4. sept 2025, 21:23 UTC

Tulu

Broadcom Stock Rises on New AI Chip Customer Order After Earnings Beat -- Barrons.com

4. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. sept 2025, 20:37 UTC

Tulu

Broadcom Posts Earnings Beat. The Stock Is Wavering. -- Barrons.com

4. sept 2025, 20:32 UTC

Omandamised, ülevõtmised, äriostud

Cadence Design Systems: 70% of Consideration to Be Paid in Cash and 30% to Be Paid Through Issuance of Stk to Hexagon >CDNS

4. sept 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

GE Aerospace Moves Toward Hybrid Electric Engines. The Stock Is Up. -- Barrons.com

4. sept 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

Cadence Design Systems Will Pay About EUR2.7 B for the Business >CDNS

4. sept 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

Cadence Design Systems: Acquisition Will Complement System Analysis Portfolio for Automotive, Aerospace, Industrial and Robotics >CDNS

4. sept 2025, 20:31 UTC

Omandamised, ülevõtmised, äriostud

Cadence Design Systems to Acquire Design & Engineering Business of Hexagon AB >CDNS

4. sept 2025, 20:25 UTC

Tulu

Broadcom Beats Earnings. The Stock Wavers. -- Barrons.com

4. sept 2025, 20:17 UTC

Tulu

Broadcom 3Q Infrastructure Software Net Revenue $6.79B >AVGO

4. sept 2025, 20:17 UTC

Tulu

Broadcom 3Q Semiconductor Solutions Net Revenue $9.17B >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom 3Q EPS 85c >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom 3Q Cont Ops EPS 85c >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom 3Q Adj EPS $1.69 >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom 3Q Net $4.14B >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom 3Q Rev $15.95B >AVGO

4. sept 2025, 20:15 UTC

Tulu

Broadcom Sees 4Q Rev $17.4B >AVGO

4. sept 2025, 19:33 UTC

Omandamised, ülevõtmised, äriostud

Private-Equity Firm Pays $2.7 Billion to Buy Back Wealth Firms It Sold Last Year -- Barrons.com

4. sept 2025, 19:33 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

4. sept 2025, 19:14 UTC

Market Talk

U.S. Natural Gas Edges Up As Storage Meets Expectations -- Market Talk

4. sept 2025, 18:48 UTC

Tulu

These Stocks Are Moving the Most Today: Figma, T. Rowe Price, Credo, Salesforce, American Eagle, HPE, Ciena, and More -- Barrons.com

4. sept 2025, 17:54 UTC

Omandamised, ülevõtmised, äriostud

T. Rowe Stock Jumps After Goldman Agrees to Invest $1 Billion, Partner on Private Funds -- WSJ

4. sept 2025, 17:54 UTC

Omandamised, ülevõtmised, äriostud

Fiserv Didn't Disclose Financial Terms of CardFree Transaction >FI

4. sept 2025, 17:54 UTC

Omandamised, ülevõtmised, äriostud

Fiserv: CardFree an All-In-One Platform Providing Merchants With Customized Order, Pay, and Loyalty Solutions >FI

4. sept 2025, 17:54 UTC

Omandamised, ülevõtmised, äriostud

Fiserv Has Acquired CardFree >FI

4. sept 2025, 17:15 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

BioArctic AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.